[Daily Excelsior]Caplin Point Laboratories arm gets USFDA nod for Neostigmine Methylsulfate Injection
New Delhi, Apr 22: Caplin Point Laboratories on Thursday said its subsidiary has received approval from the US health regulator for Neostigmine Methylsulfate Injection.Neostigmine Methylsulfate Injection is a cholinesterase inhibitor and is indicated for the reversal of the effects of non-depolariSing neuromuscular blocking agents (NMBAs) after surgery.“Caplin Steriles Ltd ...